Low dose aspirin reduces dementia risk in specific genetic groups

ScienceDaily reported that researchers at Monash University identified a link between daily low dose aspirin and a reduced risk of dementia in older adults with specific genetic traits. The clinical analysis indicated a 70 percent lower relative risk of dementia for individuals within that defined genetic subgroup. [1]

Earlier clinical trials found no overall protective effect from aspirin against cognitive decline across the general population. The new findings indicate that personal genetics determine whether the common medication provides protective benefits to brain health. [1]

Aspirin is acetylsalicylic acid, a nonsteroidal anti inflammatory drug used to reduce pain, fever, and inflammation. It is also used as an antithrombotic to treat conditions such as Kawasaki disease, pericarditis, and rheumatic fever. [2]

Researchers stated that using genetic screening could help identify which patients might benefit from low dose aspirin therapy, helping target dementia prevention strategies effectively. [1]